Literature DB >> 23656400

Crystalloid flush with backward unclamping may decrease post-reperfusion cardiac arrest and improve short-term graft function when compared to portal blood flush with forward unclamping during liver transplantation.

Kyota Fukazawa1, Seigo Nishida, Taizo Hibi, Ernesto A Pretto.   

Abstract

During liver transplant (LT), the release of vasoactive substances into the systemic circulation is associated with severe hemodynamic instability that is injurious to the recipient and/or the post-ischemic graft. Crystalloid flush with backward unclamping (CB) and portal blood flush with forward unclamping (PF) are two reperfusion methods to reduce reperfusion-related cardiovascular perturbations in our center. The primary aim of this study was to compare these two methods. After institutional review board (IRB) approval, cadaveric whole LT cases performed between 2003 and 2008 were reviewed. Patients were divided into two groups based on reperfusion methods: CB or PF. After background matching with propensity score, the effect of each method on post-operative graft function was assessed in detail. In our cohort of 478 patients, CB was used in 313 grafts and PF in 165. Thirty-day graft survival was lower, and risk of retransplantation was higher in PF. Multivariable model showed that CB is an independent factor to reduce primary non-function, cardiac arrest and improve 30-d graft survival. Also, the incidence of ischemic-type biliary lesions was significantly higher in the PF group. Reperfusion methods affect intraoperative hemodynamics and post-transplant outcome. CB allows for control over temperature and composition of the perfusate, perfusion pressure, and the rate of infusion.
© 2013 John Wiley & Sons A/S.

Entities:  

Keywords:  cardiac arrest; flush; graft function; liver transplant; portal

Mesh:

Substances:

Year:  2013        PMID: 23656400     DOI: 10.1111/ctr.12130

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  7 in total

Review 1.  Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies.

Authors:  Antonio Siniscalchi; Lorenzo Gamberini; Cristiana Laici; Tommaso Bardi; Giorgio Ercolani; Laura Lorenzini; Stefano Faenza
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

2.  Elevated effluent potassium concentrations predict the development of postreperfusion hyperkalemia in deceased liver transplantation: a retrospective cohort study.

Authors:  Liang Zhang; Fu-Shan Xue; Ming Tian; Zhi-Jun Zhu
Journal:  BMC Anesthesiol       Date:  2022-05-25       Impact factor: 2.376

3.  Association Between Flushed Fluid Potassium Concentration and Severe Postreperfusion Syndrome in Deceased Donor Liver Transplantation.

Authors:  Liang Zhang; Ming Tian; Liying Sun; Zhijun Zhu
Journal:  Med Sci Monit       Date:  2017-10-29

4.  The Impact of Implantation Time During Liver Transplantation on Outcome: A Eurotransplant Cohort Study.

Authors:  Ina Jochmans; Steffen Fieuws; Ineke Tieken; Undine Samuel; Jacques Pirenne
Journal:  Transplant Direct       Date:  2018-05-18

5.  Arrhythmogenic potential develops rapidly at graft reperfusion before the start of hypotension during living-donor liver transplantation.

Authors:  Hwa-Mi Lee; Soo-Kyoung Park; Young-Jin Moon; Jung-Won Kim; Sun-Key Kim; Bo-Hyun Sang; Dong-Kyun Seo; Byoung-Woo Yoo; Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2016-01-28

Review 6.  Expanded Criteria Donor-Related Hyperkalemia and Postreperfusion Cardiac Arrest During Liver Transplantation: A Case Report and Literature Review.

Authors:  Liang Zhang; Ming Tian; Lin Wei; Zhijun Zhu
Journal:  Ann Transplant       Date:  2018-07-03       Impact factor: 1.530

7.  Impact of reperfusion with blood venting on liver transplantation outcomes; a prospective case-control study.

Authors:  Nasir Fakhar; Abdolhamid Chavoshi Khamneh; Atabac Najafi; Ali Sharifi; Zeeshan Hyder; Javad Salimi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.